The Tau Pipeline Enabling Program (T-PEP)

The overarching goal of T-PEP is to promote the advanced study of a wide range of novel targets, agents and/or therapeutic strategies that will accelerate the development of disease modifying interventions for tauopathies. Proposals responding to this program may focus on the toxicity of tau directly and/or they may target their studies on potential neurobiological mechanisms that promote or synergize tau formation or toxicity. 

Funding: $750,000 total (matching funds is a plus)

Duration: 3 years 

Research Authority due date: 1.1.187

LOI (required) due date: 5.1.18

Full proposal due date: 2.3.18